Product Wiki · Recalls · EU Safety Gate (RAPEX)

Versus — recall A12/03328/24

EU Safety Gate (RAPEX) · Italy · 2024-11-29 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/03328/24
Date of alert
2024-11-29
Country / jurisdiction
Italy
Risk level
Serious risk
Risk type
Chemical
Brand
Versace
Product category
Cosmetics
Product type
Perfume
Reported risk: Il prodotto contiene idrossiisoesil 3-cicloesene carbossaldeide (HICC), che è vietato nei prodotti cosmetici. L'HICC può causare una reazione allergica cutanea. Il prodotto non è conforme al Regolamento sui prodotti cosmetici.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Ban on the marketing of the product and any accompanying measures
Date of entry into force
07/08/2023
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Versus

Risk Description (original English): The product contains hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), which is prohibited in cosmetic products. HICC may cause an allergic skin reaction.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10013655

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.